July 1, 2006
New Leukemia Drug Approved
U.S. regulators gave accelerated approval Wednesday to a new targeted therapy to treat people with chronic myeloid leukemia (CML).
The drug, Sprycel (generic name dasatinib), was also given regular approval to treat adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL), a more serious form of leukemia. (excite.com)
